Detailed price information for Rhythm Pharmaceuticals Inc (RYTM-Q) from The Globe and Mail including charting and trades.

Thank you. This is one of the largest unmet needs in all of medicine, and we at ClearPoint Neuro, Inc. believe we can play a ...

The AACE update to its 2026 algorithm for the management of type 2 diabetes includes a new section on diabetes classification ...

Before we begin, I would like to caution listeners that certain information discussed by management during this conference ...

Rising detection of pituitary incidentalomas has prompted a more individualized approach to surveillance and management.Incidentalomas are being found with greater frequency than in the past, ...

Life-saving treatments for children with orphan illnesses often move slowly, if at all, through the federal approval process.

PIP and Adult Disability Payment are providing financial support to over 4.4 million people in Scotland, England and Wales.

Pfizer Inc. (NYSE: PFE) today announced positive topline results from the randomized Phase 2 FOURLIGHT-1 study evaluating atirmociclib in combination with fulvestrant, versus fulvestrant or everolimus ...